<DOC>
	<DOC>NCT00231725</DOC>
	<brief_summary>Trial of new insulin injection pen called Pre-filled Pen B by type 2 diabetics in take home situations. Patients must use insulin lispro injection [rDNA origin] Low Mix twice daily during the trial.</brief_summary>
	<brief_title>Complaints Associated With Use of Pre-Filled Pen B With Type 2 Diabetics on Twice-Daily Insulin</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Insulin, Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Lispro</mesh_term>
	<criteria>Type 2 Diabetes Already on Lilly insulin or beginning insulin therapy 25 to 75 years old inclusive Currently using, or had used during previous month, oral diabetes medication that is NOT approved for use in combination with insulin in patient's country More than 3 unexplained episodes of severe hypoglycemia within 6 months prior to trial</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2007</verification_date>
</DOC>